Pre-market development times for biologic versus small-molecule drugs

Nat Biotechnol. 2019 Jul;37(7):708-711. doi: 10.1038/s41587-019-0175-2.

Reed F Beall^{1

2}, Thomas J Hwang³, Aaron S Kesselheim³

¹ Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. reed.beall@ucalgary.ca.
² Cummings School of Medicine and O'Brien Institute of Public Health, University of Calgary, Calgary, Alberta, Canada. reed.beall@ucalgary.ca.
³ Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

No abstract available

Publication types